本页面由Tiger Trade Technology Pte. Ltd.提供服务

Can-Fite Biopharma Ltd

3.08
-0.0900-2.84%
盘后3.080.00000.00%19:08 EDT
成交量:1.37万
成交额:4.25万
市值:659.90万
市盈率:0.00
高:3.16
开:3.08
低:3.07
收:3.17
52周最高:25.40
52周最低:2.90
股本:214.25万
流通股本:210.50万
量比:0.38
换手率:0.65%
股息:- -
股息率:- -
每股收益(TTM):-1,791.0249
每股收益(LYR):-3,259.3317
净资产收益率:-178.24%
总资产收益率:-66.75%
市净率:1.18
市盈率(LYR):0.00

数据加载中...

2020/01/09

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/01/08

超过5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2020/01/07

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/01/06

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/01/03

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/12/26

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/12/20

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/12/12

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/12/09

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/11/29

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/11/19

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/11/12

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/11/06

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/11/04

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/10/31

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/10/24

超过5%披露

[Amend] General statement of acquisition of beneficial ownership
2019/10/18

[修订]招股说明书

[Amend] Registration statement for certain foreign private issuers
2019/10/18

SEC问询函

[Cover]Correspondence
2019/10/17

超过5%披露

[Amend] General statement of acquisition of beneficial ownership
2019/10/17

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]